OpenCapitalBeta

Calendar Stocks Metrics

/

Stocks
Royalty Pharma
Business Segments
Products & Services
Unfunded Commitments

Unfunded Commitments

Royalty Pharma·Products & Services·3 segments·Rolls up to Unfunded Commitments

Breakdown

Segments

JNJ‑4804View metric

Total Funding, TEV-408View metric

LitifilimabView metric

Navigation

Earnings Calendar
Stocks
Pricing
About
Methodology

Connect

Claude (MCP)
ChatGPT (MCP)
Portfolio (Plaid)

Legal

Privacy Policy
Terms of Service
Cookie Policy
SEC EDGAR
support@opencapital.sh

© 2026 OpenCapital. All rights reserved.

Data sourced from SEC filings — methodology

OpenCapital is not affiliated with or endorsed by the U.S. Securities and Exchange Commission (SEC). All data is sourced from publicly available SEC filings.

OpenCapital

Segment	Q1 '26
JNJ‑4804	$500.00M
Litifilimab	$25.00M
Total	$600.00M